Sort
130,381 grants matching “hiv”
HIV Infection In Vivo And In Vitro
$1,273,878Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
HIV/SIV Replication In Vivo
$1,273,878Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
HIV Infection In Vivo And In Vitro
$1,273,878Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
HIV Sexual Risk-Reduction for African-American Couples
$1,273,780Emory University · U10 · FY2003 · MH
INTERNATIONAL TRAINING GRANT IN EPIDEMIOLOGY RELATED TO
$1,273,691University Of California Los Angeles · D43 · FY2002 · TW
HIV Testing and Treatment to Prevent Onward HIV Transmission among High-risk MSM
$1,273,480Ann C Duerr · Fred Hutchinson Cancer Research Center · R01 · FY2014 · DA
Harnessing B cells for TB vaccine development to improve therapy of TB and TB-HIV coinfection
$1,273,323Martin Alfons Gengenbacher · Hackensack University Medical Center · R01 · FY2024 · AI
AIDS INTERNATIONAL TRAINING AND RESEARCH PROGRAM
$1,273,246University Of Washington · D43 · FY2002 · TW
Administrative Core
$1,273,196David Mitchell Smith · University Of California, San Diego · P30 · FY2022 · AI
Drive to Zero: Developing a digital cohort to understand the drivers of non-sustained viral suppression in the Deep South
$1,273,106Aadia Rana · University Of Alabama At Birmingham · UG3 · FY2023 · AI
New York University HIV/AIDS Clinical Trial Unit
$1,273,058Judith Ann Aberg · New York University School Of Medicine · U01 · FY2007 · AI
Development of Ultra Long-Acting Oral HIV Therapies
$1,272,821Andrew Martin Bellinger · Lyndra Therapeutics, Inc. · R01 · FY2020 · AI
Development of Ultra Long-Acting Oral HIV Therapies
$1,272,821Stephen Zale · Lyndra Therapeutics, Inc. · R01 · FY2021 · AI
Noncoding RNAs in gamma-Herpesvirus Biology and AIDS Malignancies
$1,272,666Rolf F Renne · University Of Florida · P01 · FY2019 · CA
Crosstalk Among Oral & Gastrointestinal Soluble Innate Factors, HIV, & Microbes
$1,272,576Daniel Malamud · New York University · U19 · FY2011 · DE
India International Center for Excellence in Research
$1,272,313Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Project 1: Development of Nucleoside-Modified mRNAs Encoding Sequential HIV-1 Envelopes for Initiation of V3-glycan Neutralizing Antibody Lineages
$1,272,291Barton F Haynes · Duke University · U19 · FY2018 · AI
Expertise in Using Bitter Taste Receptor Blockers to Improve the Palatability of Pediatric Medicines: Blocker Discovery
$1,272,115Peter Silvera · Advanced Bioscience Laboratories, Inc. · N01 · FY2025 · AI
PS12-1201 COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS
$1,272,065Jennifer Brown · Utah State Department Of Health · U62 · FY2012 · PS
Vectored HIV Immunotherapy via in vivo B cell editing
$1,272,001David T Curiel · Washington University · R01 · FY2025 · AI
Biology of T Cell Depletion
$1,271,859Crystal Mackall · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
HPV &CERVIX NEOPLASIA IN A LARGE, LONG TERM HIV+ COHORT
$1,271,722Yeshiva University · R01 · FY2003 · CA
Research Resource for Human Organs and Tissues
$1,271,624Gene C Kopen · National Disease Research Interchange · U42 · FY2017 · OD
IMPLEMENTING NEW DIRECTIONS IN HIV PREVENTION IN SAN FRANCISCO: A COMPREHENSIVE C
$1,271,584Tracey Packer · Public Health Foundation Enterprises · U65 · FY2011 · PS
LEVERAGEING MMC FOR HIV PREVENTION IN KWAZULU-NATAL
$1,271,431Malebo Maponyane · Catholic Medical Mission Board, Inc. · U2G · FY2012 · GH